<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03323580</url>
  </required_header>
  <id_info>
    <org_study_id>2017-10-24</org_study_id>
    <nct_id>NCT03323580</nct_id>
  </id_info>
  <brief_title>Effects of Intraoperative GDFT on the Postoperative Brain Edema</brief_title>
  <official_title>Effects of Intraoperative Goal-directed Fluid Therapy (GDFT) on the Postoperative Brain Edema in Neurosurgical Patients With Malignant Supratentorial Gliomas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Tiantan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Whether a fluid protocol aiming for cardiac output augmentation or fluid restriction is
      favorable to post-craniotomy outcomes such as brain edema remains uncertain. To our
      knowledge, there has been no extensive and quantitative analysis of brain edema following
      SVV-based GDFT in neurosurgical patients with malignant supratentorial glioma. So the study
      aima to observe the effect of the stroke volume variation-based GDFT on the postoperative
      brain edema and decrease the incidence of postoperative complications in neurosurgical
      patients with malignant supratentorial gliomas.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 20, 2017</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quantitative analysis of brain edema</measure>
    <time_frame>Postoperative-1 day</time_frame>
    <description>The volume of high intensity area on FLAIR MRI will be measured and then subtracted the volume of gadolinium enhanced lesion on T1-weighted MRI, and then the volume ratio to the preoperative volume will be calculated</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">480</enrollment>
  <condition>Fluid Therapy</condition>
  <condition>Brain Edema</condition>
  <condition>Brain Tumor</condition>
  <arm_group>
    <arm_group_label>SVV-based GDFT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients will receive fluid therapy under SVV-directed goal.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-SVV-based GDFT group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The patients will receive fluid therapy without SVV-directed goal.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SVV-based GDFT</intervention_name>
    <description>Target SVV will be titrated with fluid bolus, and thus individual amount varied depending on the SVV value at that time. Maintenance of oxygenation, hemoglobin, blood glucose, core temperature and hemodynamics, such as minimal cardiac indices, mean arterial pressure and heart rate, will be applied according to the same standard for each patient.</description>
    <arm_group_label>SVV-based GDFT group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>traditional fluid therapy</intervention_name>
    <description>Fluid therapy will be done without goal-directed SVV . Maintenance of oxygenation, hemoglobin, blood glucose, core temperature and hemodynamics, such as minimal cardiac indices, mean arterial pressure and heart rate, will be applied according to the same standard for each patient.</description>
    <arm_group_label>non-SVV-based GDFT group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Preoperative brain image indicating high-grade glioma (HGG), verified by postoperative
             histology of the World Health Organization (WHO) as grade III or IV tumors.

          2. Age 18 -80 years.

          3. Undergoing supratentorial brain tumour resection.

          4. Signed informed consent.

        Exclusion Criteria:

          1. Renal insufficiency or the creatinine clearance is &lt; 30 mL/kg.

          2. Heart disease, New York Heart Association Functional Classification (NYHA) class II or
             higher heart failure, or if their cardiac ejection fraction is &lt; 20%.

          3. Chronic obstructive pulmonary disease.

          4. Extensive peripheral arterial occlusive disease.

          5. Coagulopathy.

          6. Surgery in the prone position.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Beijing Tiantan Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuming Peng, MD</last_name>
      <phone>8610-67096658</phone>
      <email>florapym766@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Jia Dong</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2017</study_first_submitted>
  <study_first_submitted_qc>October 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2017</study_first_posted>
  <last_update_submitted>March 17, 2018</last_update_submitted>
  <last_update_submitted_qc>March 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tiantan Hospital</investigator_affiliation>
    <investigator_full_name>Yuming Peng</investigator_full_name>
    <investigator_title>Ph.D.,M.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Edema</mesh_term>
    <mesh_term>Brain Edema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

